- Home
- RCKT vs LMAT Comparison
RCKT vs LMAT Comparison
Compare RCKT & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- LMAT
- Stock Information
- Founded
- RCKT 1999
- LMAT 1983
- Country
- RCKT United States
- LMAT United States
- Employees
- RCKT N/A
- LMAT N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- LMAT Medical/Dental Instruments
- Sector
- RCKT Health Care
- LMAT Health Care
- Exchange
- RCKT Nasdaq
- LMAT Nasdaq
- Market Cap
- RCKT 328.6M
- LMAT 1.9B
- IPO Year
- RCKT N/A
- LMAT 2006
- Fundamental
- Price
- RCKT $3.03
- LMAT $92.11
- Analyst Decision
- RCKT Buy
- LMAT Buy
- Analyst Count
- RCKT 13
- LMAT 6
- Target Price
- RCKT $12.96
- LMAT $99.67
- AVG Volume (30 Days)
- RCKT 5.7M
- LMAT 172.9K
- Earning Date
- RCKT 11-06-2025
- LMAT 10-30-2025
- Dividend Yield
- RCKT N/A
- LMAT 0.87%
- EPS Growth
- RCKT N/A
- LMAT 22.69
- EPS
- RCKT N/A
- LMAT 2.05
- Revenue
- RCKT N/A
- LMAT $234,639,000.00
- Revenue This Year
- RCKT N/A
- LMAT $16.32
- Revenue Next Year
- RCKT $108.43
- LMAT $8.62
- P/E Ratio
- RCKT N/A
- LMAT $45.02
- Revenue Growth
- RCKT N/A
- LMAT 14.11
- 52 Week Low
- RCKT $2.19
- LMAT $71.42
- 52 Week High
- RCKT $22.01
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- RCKT 42.39
- LMAT 45.86
- Support Level
- RCKT $3.09
- LMAT $91.24
- Resistance Level
- RCKT $3.29
- LMAT $98.93
- Average True Range (ATR)
- RCKT 0.17
- LMAT 2.58
- MACD
- RCKT -0.03
- LMAT -0.88
- Stochastic Oscillator
- RCKT 0.00
- LMAT 16.01
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.